Here Is An Indian Startup That Makes Accident Experiences Less Traumatic
Almost every one of us must have seen a fresh accident victim while travelling on the way or otherwise. Some of us help them while some of us just become sympathetic or empathetic for the moment and then get occupied in our day-to-day business. Thankfully, there are a few thinking minds who take strides to make not only one but many accident victims’ lives better.
Leo Sebastian Mavely is one such person. Once during his college days, Leo had a life changing experience when he helped a road accident victim bleeding profusely from his injuries. It was then that he recognised the need to develop a product that can help accident victims having traumatic bleeding – saving many lives. Today, Leo is spearheading Axio Biosolutions Private Limited, a global name that uses innovative medical technology to create breakthrough products and improve people’s lives.
According to a recent report by the Ministry of Road Transport (Government of India), there are 1324 accidents that occur on Indian roads on an average day – leading to the death of 349 people. This means 55 accidents and 15 lives are lost per hour, which in other words means, a life is lost in every four minutes. Most of these fatalities can be avoided if they are provided with an aid to stop uncontrolled bleeding.
With its unique and patented sponge-like dressing that stops bleeding within minutes, Axio’s products are transforming the wound-care market with life-saving technologies. In fact, life-threatening bleeding continues to be the major cause of concern in cases of accidents and traumatic injuries, not only in India but the world over. The products are based on an empathetic understanding of real problems in the medical space with solutions that have wide applications.
Established in 2008 in a startup incubator in Ahmedabad, Axio Biosolutions Private Limited, Nearly a decade later, Axio has today become a unique technology-led-healthcare company from India that is revolutionising the ‘advanced wound care market’ across the globe. With parent company, Advamedica Inc, based in Massachusetts, United States, Axio has been funded by marquee investors such as Accel Partners, IDG Ventures and GVFL. Driving this innovation is the 50+ member Axio team of the medical device and biopharma industry veterans in offices spread across India and USA.
Recognizing the need to address these unmet wound care challenges globally, Axio developed an innovative solution that could reduce the mortality rate due to traumatic bleeding and save precious lives. The company’s products are currently being used by Military, Hospitals, Ambulance services, Industries, Relief aid and are part of the standard field kit of defence forces in many countries.
Moving with the times
Axiostat was approved for use in India in 2011 and is sold to the Indian Military and hospitals across the country for their use. Its customers include numerous government hospitals and reputed private institutions such as AIIMS, Manipal, Apollo, Breach Candy and Fortis. In the $1.7 billion global haemostat market, which is expected to become $2.5 billion by 2020, Axio today is a name to reckon with.
Adjudged the best-emerging start-up by BioAsia in 2016, Axio is rapidly growing in the Middle East, Africa and European markets. The company was recently featured as one of the 10 Medical Marvels poised to Save Life’ by India Today magazine. In India, the company’s backbone is its trained team of distributors in eight states with ready access to training and demo. Winning an array of innovation awards since 2012, the company also boasts of an ISO 13485 certification and the European CE Mark of approval.
The Turning Point
The Axiostat dressing was famously used in the 2014 Russia-Ukraine conflict and earned Mavely a spot in the ‘Fortune 40 under 40’ India list of emerging business leaders. Axiostat also received European Union-CE approval in 2013, which was yet another major validation of the product and its technology.
Axio’s vision is to become the first choice for any customer looking for advanced, affordable wound care solutions worldwide. To make that happen, Axio has a fully functioning modern Research and Development (R&D) wing registered in Bangalore with a GMP, ISO 13485 manufacturing facility situated in Ahmedabad, Gujarat. Still primarily a development and innovation company, Axio’s core strength is expertise in biomaterials. With a strong R&D team led by leading research scientists, the company makes considerable allocation into R&D spend every year. Axio is currently aiming its product at the cardiology segment, where it feels its application will allow access to advanced, affordable healthcare for all.
Right from saving lives in kite festivals to reducing medical interventions on enemy lines, Axio has its path set to revolutionise the global market by making healthcare better and affordable for everyone. With Axio, India is leading the way into the affordable, innovative and effective healthcare market.
May more innovators like Leo Sebastian come up with their ventures to add values to others lives in the true sense. May India transform its image from a follower to a leader in innovations.